Repligen | RGEN - 现金及等价物



金融业
股票价格
USD
资产
USD 2.95B
现金及等价物
USD 606.78M
销售成本
USD 94.09M
流动资产
USD 1.2B
流动负债
USD 132.66M
债务
USD 690.94M
EBIT
USD 21.13M
EBITDA
USD 43.77M
员工
1.78K
EPS每股收益
USD 0.54
股本和储备
USD 2.11B
销售毛利
USD 110.04M
债务利息支出
USD 5.66M
利息收入
USD 7.31M
贷款资金
USD 551.05M
市值
USD 9.27B
净收入
USD 5.01M
营业费用
USD 183M
营业利润
USD 21.13M
普通股股本
USD 56.43M
PE价格收益
105.09
税前利润
USD 14.15M
销售收入
USD 204M
销售和管理费用
USD 76.62M
股票
USD 186.6M
贸易债权人
USD 33.23M
应收帐款人
USD 157.71M


现金及等价物 更改 日
Agilent USD 1.81B 49M 2026-03
Align Technology USD 1.1B 42.76M 2026-06
Bio Techne USD 264.71M 54.89M 2026-06
BioMarin Pharmaceutical USD 874M 1.35B 2026-06
Bristol-Myers Squibb USD 8.72B 852M 2026-06
Bruker USD 184.9M 51.5M 2026-06
Charles River Laboratories USD 192.02M 195K 2026-06
Danaher USD 4.35B 1.35B 2026-06
Dentsply International USD 239M 49M 2026-06
General Electric Aerospace USD 9.35B 1.64B 2026-06
Henry Schein USD 157M 19M 2026-06
Illumina USD 1.09B 329M 2026-03
IQVIA Holdings USD 1.91B 38M 2026-06
Mettler Toledo International USD 51.38M 9.19M 2026-06
Myriad Genetics USD 115.2M 9.2M 2026-06
OraSure Technologies USD 160.58M 16.38M 2026-06
Pacific Biosciences Of California USD 61M 4.73M 2026-06
Pfizer USD 976M 727M 2026-06
Repligen USD 606.78M 24.13M 2026-06
Revvity USD 1.02B 162.62M 2026-06
Standard Biotools USD 265.77M 147.56M 2026-03
Thermo Fisher Scientific USD 3.25B 6.6B 2026-03
Waters USD 539M 77M 2026-06
West Pharmaceutical Services USD 435.8M 85.6M 2026-06